Isabel Krsnik

2.8k total citations
39 papers, 760 citations indexed

About

Isabel Krsnik is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Isabel Krsnik has authored 39 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 18 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Isabel Krsnik's work include Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Isabel Krsnik is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Isabel Krsnik collaborates with scholars based in Spain, Uruguay and Netherlands. Isabel Krsnik's co-authors include Julio García‐Suárez, Carmen Burgaleta, Dunia de Miguel, Helena Bañas, Ignacio Arribas, Pablo García‐Pavía, Giuseppe Milone, Josep‐María Ribera, Rafael Forés and Emilio Ojeda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Isabel Krsnik

37 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Krsnik Spain 12 398 379 200 192 74 39 760
Ana Vidović Serbia 13 192 0.5× 406 1.1× 165 0.8× 89 0.5× 74 1.0× 74 585
Hanyun Ren China 16 224 0.6× 618 1.6× 131 0.7× 329 1.7× 153 2.1× 114 1.1k
Jochen Wilpert Germany 15 128 0.3× 156 0.4× 86 0.4× 98 0.5× 151 2.0× 17 776
Antonella Di Mario Italy 13 155 0.4× 253 0.7× 107 0.5× 92 0.5× 40 0.5× 30 465
Anu Korula India 14 202 0.5× 394 1.0× 102 0.5× 209 1.1× 142 1.9× 112 724
Julius Fischer Germany 13 152 0.4× 263 0.7× 102 0.5× 158 0.8× 19 0.3× 45 852
Patricia Molina Spain 15 211 0.5× 157 0.4× 24 0.1× 140 0.7× 11 0.1× 31 776
Christoph Caliezi Switzerland 7 111 0.3× 186 0.5× 155 0.8× 34 0.2× 37 0.5× 13 704
Ryu Yanagisawa Japan 17 249 0.6× 340 0.9× 89 0.4× 520 2.7× 70 0.9× 93 1.1k
Chalmette Ball United States 8 86 0.2× 586 1.5× 172 0.9× 48 0.3× 39 0.5× 9 1.1k

Countries citing papers authored by Isabel Krsnik

Since Specialization
Citations

This map shows the geographic impact of Isabel Krsnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Krsnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Krsnik more than expected).

Fields of papers citing papers by Isabel Krsnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Krsnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Krsnik. The network helps show where Isabel Krsnik may publish in the future.

Co-authorship network of co-authors of Isabel Krsnik

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Krsnik. A scholar is included among the top collaborators of Isabel Krsnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Krsnik. Isabel Krsnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krsnik, Isabel, Manuel Gómez‐Bueno, Pablo García‐Pavía, et al.. (2023). AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor. Life. 13(7). 1518–1518. 9 indexed citations
2.
Duarte, Rafael F., et al.. (2021). Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma. SHILAP Revista de lepidopterología. 2(3). 646–647. 1 indexed citations
3.
Lecumberri, Ramón, Isabel Krsnik, Marta Sonia González, et al.. (2020). Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature. Amyloid. 27(3). 163–167. 25 indexed citations
4.
López‐Sainz, Ángela, F. Javier de Haro-del Moral, Fernándo Domínguez, et al.. (2019). Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders. Amyloid. 26(3). 156–163. 38 indexed citations
5.
Moral, F. Javier de Haro-del, Fernándo Domínguez, Clara Salas, et al.. (2019). Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome. Journal of Cardiovascular Translational Research. 12(6). 507–513. 35 indexed citations
6.
Segovia, Javier, Jesús G. Mirelis, Isabel Krsnik, et al.. (2019). Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis. Journal of the American Society of Echocardiography. 32(7). 845–853.e1. 34 indexed citations
7.
Martín, Paloma, María José Coronado, Isabel Krsnik, et al.. (2016). Association of DDX58 177 C > T polymorphism with decreased risk of Epstein–Barr virus-related nodular sclerosis classical Hodgkin lymphoma. Leukemia & lymphoma. 58(2). 438–444. 3 indexed citations
8.
Krsnik, Isabel, Manuel Gómez‐Bueno, Pablo García‐Pavía, et al.. (2016). Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis. The Journal of Heart and Lung Transplantation. 35(8). 995–1002. 17 indexed citations
9.
Martín, Paloma, Isabel Krsnik, Belén Navarro, et al.. (2015). HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. PLoS ONE. 10(8). e0135512–e0135512. 9 indexed citations
10.
11.
Krsnik, Isabel, Daniel Morillo, Javier Segovia, et al.. (2014). Light chain amyloidosis: Experience in a tertiary hospital: 2005–2013. Revista Clínica Española (English Edition). 215(1). 1–8. 4 indexed citations
12.
Gómez‐Bueno, Manuel, Javier Segovia, Pablo García‐Pavía, et al.. (2009). Cardiac Amyloidosis: The Importance of a Multidisciplinary Approach. Revista Española de Cardiología (English Edition). 62(6). 698–702. 3 indexed citations
13.
Gonzalo‐Daganzo, Rosa M., C Regidor, Trinidad Martín-Donaire, et al.. (2009). Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy. 11(3). 278–288. 90 indexed citations
14.
Martín-Donaire, Trinidad, M Rico, Rosa M. Gonzalo‐Daganzo, et al.. (2009). Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplantation. 44(4). 213–225. 15 indexed citations
15.
Cabrera, José Rafael, C Regidor, Rafael Forés, et al.. (2008). Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplantation. 43(5). 365–373. 74 indexed citations
16.
17.
García‐Suárez, Julio, et al.. (2002). Spontaneous gas gangrene in malignant lymphoma: An underreported complication?. American Journal of Hematology. 70(2). 145–148. 15 indexed citations
18.
Krsnik, Isabel, et al.. (2001). Translocation t(4; 6)(q21; q27) in a case of primary thrombocythaemia in transformation. Clinical & Laboratory Haematology. 23(4). 259–260. 2 indexed citations
19.
Ferró, Teresa, et al.. (1993). Deletion(2)(p23) abnormality in a case of secondary acute myeloid leukemia. Cancer Genetics and Cytogenetics. 66(2). 126–127. 4 indexed citations
20.
Ferrò, Maria Teresa, et al.. (1991). Unusual translocations and other changes in acute leukemia. Cancer Genetics and Cytogenetics. 54(2). 163–171. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Vidović Breakdown of academic impact, for papers by Hanyun Ren Breakdown of academic impact, for papers by Jochen Wilpert Breakdown of academic impact, for papers by Antonella Di Mario Breakdown of academic impact, for papers by Anu Korula Breakdown of academic impact, for papers by Julius Fischer Breakdown of academic impact, for papers by Patricia Molina Breakdown of academic impact, for papers by Christoph Caliezi Breakdown of academic impact, for papers by Ryu Yanagisawa Breakdown of academic impact, for papers by Chalmette Ball
Rankless by CCL
2026